Insider Selling: Ingevity (NYSE:NGVT) SVP Sells 496 Shares of Stock

by · The Markets Daily

Ingevity Corporation (NYSE:NGVT – Get Free Report) SVP Terrance Dyer sold 496 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the transaction, the senior vice president directly owned 7,202 shares in the company, valued at $493,264.98. The trade was a 6.44% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Ingevity Stock Performance

NGVT stock traded down $2.06 during mid-day trading on Monday, reaching $65.76. 132,057 shares of the stock traded hands, compared to its average volume of 301,640. The company has a quick ratio of 0.92, a current ratio of 1.42 and a debt-to-equity ratio of 27.83. Ingevity Corporation has a 52 week low of $39.74 and a 52 week high of $79.29. The business has a 50-day moving average of $71.64 and a two-hundred day moving average of $65.86. The firm has a market capitalization of $2.29 billion, a PE ratio of -18.51 and a beta of 1.18.

Ingevity (NYSE:NGVT – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The company had revenue of $258.00 million during the quarter, compared to analysts’ expectations of $254.73 million. During the same period in the prior year, the company earned $1.01 earnings per share. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. As a group, equities analysts predict that Ingevity Corporation will post 5.05 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on NGVT. BMO Capital Markets restated an “outperform” rating and set a $83.00 price target on shares of Ingevity in a report on Monday, March 2nd. Wall Street Zen upgraded shares of Ingevity from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 9th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a report on Tuesday, April 21st. Wells Fargo & Company increased their target price on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 27th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $82.00 target price on shares of Ingevity in a research note on Thursday, February 26th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Ingevity presently has a consensus rating of “Hold” and an average price target of $80.00.

Read Our Latest Stock Analysis on NGVT

Institutional Trading of Ingevity

Several hedge funds have recently modified their holdings of NGVT. Assetmark Inc. increased its holdings in shares of Ingevity by 9.6% in the first quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock valued at $113,000 after purchasing an additional 139 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Ingevity by 3.1% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 7,823 shares of the company’s stock valued at $418,000 after purchasing an additional 238 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Ingevity by 15.7% in the third quarter. EverSource Wealth Advisors LLC now owns 1,870 shares of the company’s stock valued at $103,000 after purchasing an additional 254 shares in the last quarter. Advisory Services Network LLC increased its holdings in shares of Ingevity by 4.4% in the third quarter. Advisory Services Network LLC now owns 6,947 shares of the company’s stock valued at $383,000 after purchasing an additional 293 shares in the last quarter. Finally, Amundi increased its holdings in shares of Ingevity by 4.8% in the third quarter. Amundi now owns 6,626 shares of the company’s stock valued at $364,000 after purchasing an additional 302 shares in the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

See Also